close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by UsAgainstAlzheimer's

News headline image
New Report Offers Recommendations to Advance Brain Capital for Economic and Workforce Growth
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Houston Emerges as Global Center for Brain Health Innovation
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
UPDATE: Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
UsAgainstAlzheimer’s Launches 2024 Brain Health Academy
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Congress Passes Bills Making Major Investments in Alzheimer’s
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Organizations Unite to Improve Brain Health
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Brain Health Academy Enrollment is Now Open, First Session Launches May 17
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
Sen. Collins, Rep. Eshoo Decry Medicare Coverage Rejection of Alzheimer’s Drugs
From UsAgainstAlzheimer's
Via GlobeNewswire
News headline image
TODAY: CMS Controversy, Rep. Eshoo, Nationally Recognized Scientists to Take Center Stage at UsAgainstAlzheimer’s National Summit
From UsAgainstAlzheimer's
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today